CONTRIBUTION OF ALPHA-INTERFERON (ALPHA-IFN) TO HIV-INDUCED IMMUNOSUPPRESSION

被引:0
|
作者
LACHGAR, A
BIZZINI, B
机构
关键词
HIV INFECTION; IMMUNOSUPPRESSION; ALPHA INTERFERON; INACTIVATION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present investigation we have shown that PBLs taken from HIV-positive patients suppressed T-cell proliferation when cultured for at least 12 days. When infected In vitro with HIV-1, these cells become suppressive after 6 days. PBLs collected from seronegative individuals turned out to be non-suppressive even after prolonged culturing. However, when infected in vitro with HIV they were found to be cytostatic also after 6 days. This anti-immune activity, related to HIV infection, is mediated, at least in part, by alpha IFN, since about 50% of this HIV associated activity could be quenched by alpha IFN antibodies. We also showed that this T-cell cytostasis is associated with CD8(+) cells. In view of a possible use of suppressive cells for T-cell vaccination, we verified that such cellular functions were abolished by aldehyde treatment.
引用
收藏
页码:431 / 437
页数:7
相关论文
共 50 条
  • [31] Parameters predicting response to alpha-interferon treatment in chronic hepatitis C
    Gluck, T
    Seelig, R
    Dette, S
    Buhring, HJ
    Renz, M
    Kwon, S
    Wiedmann, KH
    Weber, P
    HEPATO-GASTROENTEROLOGY, 1997, 44 (14) : 484 - 491
  • [32] AN UNUSUAL REACTION TO ALPHA-INTERFERON IN A CASE OF NON-HODGKINS-LYMPHOMA
    MIGLINO, M
    PIERRI, I
    CANEPA, L
    CARRARA, P
    CELESTI, L
    GOBBI, M
    HAEMATOLOGICA, 1993, 78 (06) : 411 - 413
  • [33] MICROGLIAL LOCALIZATION OF ALPHA-INTERFERON RECEPTOR IN HUMAN BRAIN-TISSUES
    YAMADA, T
    YAMANAKA, L
    NEUROSCIENCE LETTERS, 1995, 189 (02) : 73 - 76
  • [34] Cavernous haemangioma with Kasabach-Merritt syndrome: Treatment with alpha-interferon
    Ettlinger, JJ
    Fleming, PJ
    Joffe, HS
    Kennedy, CTC
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1996, 89 (01) : P55 - P56
  • [35] EFFECTS OF PROPHYLACTIC USE OF ALPHA-INTERFERON FOR PATIENTS WITH RENAL-CANCER
    UCHIBAYASHI, T
    KOSHIDA, K
    NAGANO, K
    HISAZUMI, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (05) : 1111 - 1114
  • [36] PROLONGED THROMBOCYTOPENIA FOLLOWING ALPHA-INTERFERON FOR REFRACTORY IMMUNE THROMOBOCYTOPENIC PURPURA
    STERN, SCM
    ASAGBA, GO
    HEDGE, UM
    CLINICAL AND LABORATORY HAEMATOLOGY, 1994, 16 (02): : 183 - 185
  • [37] COMBINED DOXORUBICIN AND ALPHA-INTERFERON THERAPY OF ADVANCED HEPATOCELLULAR-CARCINOMA
    KARDINAL, CG
    MOERTEL, CG
    WIEAND, HS
    SCHUTT, AJ
    OCONNELL, MJ
    WRIGHT, K
    WIESENFELD, M
    TSCHETTER, LK
    KROOK, JE
    CANCER, 1993, 71 (07) : 2187 - 2190
  • [38] ALPHA-INTERFERON - NEW ASSOCIATIONS IN HEMATOLOGY-ONCOLOGY - THE MONTPELLIER EXPERIENCE
    ROSSI, JF
    MEDICAL ONCOLOGY, 1995, 12 (01): : 59 - 61
  • [39] TREATMENT OF RENAL-CELL CARCINOMA WITH ESCALATING DOSES OF ALPHA-INTERFERON
    TSAVARIS, N
    MYLONAKIS, N
    BACOYIANNIS, C
    TSOUTSOS, H
    KARABELIS, A
    KOSMIDIS, P
    CHEMOTHERAPY, 1993, 39 (05) : 361 - 366
  • [40] SUSTAINED REMISSION OF IDIOPATHIC HYPEREOSINOPHILIC SYNDROME FOLLOWING ALPHA-INTERFERON THERAPY
    FRUEHAUF, S
    FIEHN, C
    HAAS, R
    DOEHNER, H
    HUNSTEIN, W
    ACTA HAEMATOLOGICA, 1993, 89 (02) : 91 - 93